Breast Cancer News

    21.12.09 18:40 Age: 261 days

    Institut Paoli Calmettes and IPSOGEN presented a new study supporting the pivotal role of tumor grade in chemotherapy prescription at the 32nd Annual San Antonio Breast Cancer Symposium

    Category: Breast Cancer Breast Cancer

     

    The study reinforces tumor grade as the most contributive factor for adjuvant chemotherapy in N-/M- IBC, together with tumor size

    Marseille, France, Dec 21, 2009 – Ipsogen SA (Alternext: ALIPS) today announced that a new study confirming the pivotal role of tumor grade in chemotherapy prescription has been presented at the 32nd Annual San Antonio Breast Cancer Symposium (SABCS),  December 9-13, 2009.

    More

    <- Back to: Healthcare Professionnals